968 PD-1hiFoxp3-CD4+ tumor-infiltrating T-cell lineage commitment impacts the immunotherapy outcome
Main Authors: | Jedd D Wolchok, Taha Merghoub, Roberta Zappasodi, Sara Schad, Benjamin Greenbaum, Levi Mark Mangarin, Stephen Martis, Andrea Orlando |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1444 Pharmacologic LDH inhibition redirects intratumoral glucose consumption and improves response to CTLA-4 blockade
by: Jedd D Wolchok, et al.
Published: (2023-11-01) -
Erratum: Human CD4+CD25hiFoxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo (Journal of Clinical Investigation (2006) 116 (2423-2433) DOI:10.1172/JCI28941)
by: Vukmanovic-Stejic, M, et al.
Published: (2006) -
Erratum: Human CD4+CD25hiFoxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo (Journal of Clinical Investigation (2006) 116 (2423-2433) DOI:10.1172/JCI28941)
by: Vukmanovic-Stejic, M, et al.
Published: (2006) -
Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant
by: Ning Yang, et al.
Published: (2022-10-01) -
525 Investigating dynamic IDO-Kyn-AhR pathway-induced tumor immunosuppression using imaging modality to optimize AhR therapeutic intervention
by: Jedd D Wolchok, et al.
Published: (2023-11-01)